299 related articles for article (PubMed ID: 10428711)
1. Race for molecular summits.
Service RF
Science; 1999 Jul; 285(5425):184-5, 187. PubMed ID: 10428711
[No Abstract] [Full Text] [Related]
2. Organic synthesis in flow for medicinal chemistry.
Wirth T
Bioorg Med Chem; 2017 Dec; 25(23):6179. PubMed ID: 29153554
[No Abstract] [Full Text] [Related]
3. Drug industry looks to the lab instead of rainforest and reef.
Service RF
Science; 1999 Jul; 285(5425):186. PubMed ID: 10428712
[No Abstract] [Full Text] [Related]
4. Impact of continuous flow chemistry in the synthesis of natural products and active pharmaceutical ingredients.
Souza JM; Galaverna R; Souza AAN; Brocksom TJ; Pastre JC; Souza ROMA; Oliveira KT
An Acad Bras Cienc; 2018; 90(1 Suppl 2):1131-1174. PubMed ID: 29873673
[TBL] [Abstract][Full Text] [Related]
5. "Macho total synthesis".
Djerassi C
Science; 1999 Aug; 285(5429):835. PubMed ID: 10454928
[No Abstract] [Full Text] [Related]
6. Catalytic enantioselective synthesis of quaternary carbon stereocentres.
Quasdorf KW; Overman LE
Nature; 2014 Dec; 516(7530):181-91. PubMed ID: 25503231
[TBL] [Abstract][Full Text] [Related]
7. Combinatorial chemistry hits the drug market.
Service RF
Science; 1996 May; 272(5266):1266-8. PubMed ID: 8650537
[No Abstract] [Full Text] [Related]
8. Organic synthesis remains relevant in drug discovery.
Mehrotra MM
Nature; 2007 Oct; 449(7162):535. PubMed ID: 17914370
[No Abstract] [Full Text] [Related]
9. Multicomponent reactions in solid-phase synthesis.
Banfi L; Guanti G; Riva R; Basso A
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):704-14. PubMed ID: 17987522
[TBL] [Abstract][Full Text] [Related]
10. The 15th Frank Warren Organic Chemistry Conference.
Veale CGL
ChemMedChem; 2019 Nov; 14(21):1873-1877. PubMed ID: 31539201
[TBL] [Abstract][Full Text] [Related]
11. Organic chemistry in drug discovery.
MacCoss M; Baillie TA
Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
[TBL] [Abstract][Full Text] [Related]
12. Target-oriented and diversity-oriented organic synthesis in drug discovery.
Schreiber SL
Science; 2000 Mar; 287(5460):1964-9. PubMed ID: 10720315
[TBL] [Abstract][Full Text] [Related]
13. Claisen rearrangement over the past nine decades.
Martín Castro AM
Chem Rev; 2004 Jun; 104(6):2939-3002. PubMed ID: 15186185
[No Abstract] [Full Text] [Related]
14. Chemistry: Why synthesize?
Ball P
Nature; 2015 Dec; 528(7582):327-9. PubMed ID: 26672538
[No Abstract] [Full Text] [Related]
15. Optimization in organic synthesis.
Snieckus V
Med Res Rev; 1999 Sep; 19(5):342-7. PubMed ID: 10502738
[No Abstract] [Full Text] [Related]
16. Modern Synthetic Methods & Chiral USA--a scientific update conference. Reaction to Reality. 11-13 July 2007, Philadelphia, PA, USA.
Bakale R
IDrugs; 2007 Oct; 10(10):703-5. PubMed ID: 17899487
[No Abstract] [Full Text] [Related]
17. Deciding whether to go with the flow: evaluating the merits of flow reactors for synthesis.
Hartman RL; McMullen JP; Jensen KF
Angew Chem Int Ed Engl; 2011 Aug; 50(33):7502-19. PubMed ID: 21710673
[TBL] [Abstract][Full Text] [Related]
18. American Chemical Society--228th National Meeting. Technical achievements in organic synthesis. 22-26 August 2004, Philadelphia, PA, USA.
Rotella DP
IDrugs; 2004 Oct; 7(10):889-92. PubMed ID: 15478006
[No Abstract] [Full Text] [Related]
19. Development of Highly Chemoselective Oxidative Transformations by Designing Organoradicals.
Oisaki K
Chem Pharm Bull (Tokyo); 2018; 66(10):907-919. PubMed ID: 30270237
[TBL] [Abstract][Full Text] [Related]
20. Anticancer drug discovery and pharmaceutical chemistry: a history.
Braña MF; Sánchez-Migallón A
Clin Transl Oncol; 2006 Oct; 8(10):717-28. PubMed ID: 17074670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
